Heather Stone
Health science policy analyst at the U.S. Food and Drug Administration who discusses clinical examples of repurposed drugs and helped create the CureID treatment registry.
Best podcasts with Heather Stone
Ranked by the Snipd community
372 snips
Feb 20, 2026 • 52min
664. Are Thousands of Medical Cures Hiding in Plain Sight?
Chris Snyder, economist at Dartmouth who designs market incentives; Heather Stone, FDA policy analyst who built the CureID registry; David Fajgenbaum, physician-scientist who survived Castleman disease and leads EveryCure. They explore drug repurposing, AI and knowledge graphs to match drugs to diseases, crowdsourced registries for real-world cases, and economic pull incentives to make trials and generic repurposing viable.
